ParkerVision reports $7.4M net loss; Qualcomm appeal expedited, MediaTek trial postponed

PARKERVISION INC

Net loss of $7.4M ($0.06/share) vs. $14.5M loss in 2024; improvement driven by $0.6M gain on contingent payment obligations.
Cash and cash equivalents $4.4M; working capital $2.3M as of Dec 31, 2025.
Completed $4.5M registered direct offering (21.2M shares at $0.21) in Nov 2025 and $0.67M share issuance in Mar 2026.
CAFC granted expedited appeal schedule in ParkerVision v. Qualcomm; briefings completed Mar 23, 2026.
First MediaTek trial postponed from Mar 20, 2026; court requests updated expert reports.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

PARKERVISION INC reported the year ended December 31, 2025 results: net income net loss of $7.4 million, EPS $0.06 per common share.

Period: the year ended December 31, 2025
Net income: net loss of $7.4 million
EPS: $0.06 per common share
Result: reported results

Exact text from the filing

ParkerVision reported a net loss for the year ended December 31, 2025 of $7.4 million, or $0.06 per common share, compared to a net loss of $14.5 million, or $0.16 per common share for the year ended December 31, 2024.

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

PARKERVISION INC filing history →

Source: SEC EDGAR

accession 0001437749-26-009390

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.